[1] Sian-Hülsmann J, Mandel S, Youdim MBH, et al. The relevance of iron in the pathogenesis of Parkinson’s disease [J]. J Neurochem, 2011, 118(6):939-957.
[2] Eskreis-Winkler S, Zhang Y, Zhang J, et al. The clinical utility of QSM: disease diagnosis, medical management, and surgical planning [J]. NMR Biomed, 2017, 30(4):e3668.
[3] Li W, Wu B, Liu CL. STI suite: a software package for quantitative susceptibility imaging [C]. Proc Intl Soc Mag Reson Med, 2014, 22(2014):3265.
[4] Tustison NJ, Avants BB, Cook PA, et al. N4ITK: improved N3 bias correction [J]. IEEE Trans Med Imaging, 2010, 29(6):1310-1320.
[5] Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL [J]. NeuroImage, 2004, 23(Suppl 1):S208-S219.
[6] Feng X, Deistung A, Dwyer MG, et al. An improved FSL-FIRST pipeline for subcortical gray matter segmentation to study abnormal brain anatomy using quantitative susceptibility mapping (QSM) [J]. Magn Reson Imaging, 2017, 39:110-122.
[7] Avants BB, Tustison N, Song G. Advanced normalization tools (ANTS) [J]. Insight J, 2009, 2:1-35.
[8] Avants BB, Tustison NJ, Song G, et al. A reproducible evaluation of ANTs similarity metric performance in brain image registration [J]. NeuroImage, 2011, 54(3):2033-2044.
[9] Dice LR. Measures of the amount of ecologic association between species [J]. Ecology, 1945, 26(3):297-302.
[10] He N, Ling H, Ding B, et al. Region-specific disturbed iron distribution in early idiopathic Parkinson’s disease measured by quantitative susceptibility mapping [J]. Hum Brain Mapp, 2015, 36(11):4407-4420.
[11] Lee SH, Kim SS, Tae WS, et al. Regional volume analysis of the parkinson disease brain in early disease stage: gray matter, white matter, striatum, and thalamus [J]. AJNR, 2011, 32(4):682-687.
[12] Pitcher TL, Melzer TR, MacAskill MR, et al. Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study [J]. Transl Neurodegener, 2012, 1(1):1-8.
[13] Liu GX, Shi YH, Wang ShQ, et al. Differential analysis of brain structure volume associated with Parkinson s disease based on nuclear magnetic resonance T1 imaging [J]. Acta Anatomica Sinica, 2018,49(3):78-85.(in Chinese)
刘桂雪, 史勇红, 王士卿, 等. 基于磁共振T1成像的帕金森病相关脑结构体积差异性分析[J]. 解剖学报, 2018, 49(3):78-85.
[14] Zecca L, Stroppolo A, Gatti A, et al. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging [J]. Proc Natl Acad Sci USA, 2004, 101 (26): 9843-9848.
[15] Deistung A, Sch?fer A, Schweser F, et al. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2* -imaging at ultra-high magnetic field strength [J]. NeuroImage, 2013, 65(2013):299-314.
[16] Langkammer C, Schweser F, Krebs N, et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study [J]. Neuroimage, 2012, 62(3):1593-1599.
[17] Dexter DT, Wells FR, Agid F, et al. Increased nigral iron content in postmortem parkinsonian brain [J]. The Lancet, 1987, 330(8569):1219-1220.
[18] Griffiths PD, Crossman AR. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson’s disease and Alzheimer’s disease [J]. Dement Geriatr Cogn, 1993, 4(2):61-65.
[19] Dusek P, Roos PM, Litwin T, et al. The neurotoxicity of iron, copper and manganese in Parkinson’s and Wilson’s diseases [J]. J Trace Elem Med Biol, 2015, 31(2015):193-203.
[20] Murakami Y, Kakeda S, Watanabe K, et al. Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease [J]. AJNR, 2015, 36(6):1102-1108
[21] Langkammer C, Pirpamer L, Seiler S, et al. Quantitative susceptibility mapping in Parkinson’s disease [J]. PLoS One, 2016, 11(9):e0162460.
[22] Lotfipour AK, Wharton S, Schwarz ST, et al. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson’s disease [J]. J Magn Reson Imaging, 2012, 35(1):48-55.
[23] Guan X, Xuan M, Gu Q, et al. Influence of regional iron on the motor impairments of Parkinson’s disease: a quantitative susceptibility mapping study [J]. J Magn Reson Imaging, 2017, 45(5):1335-1342.
[24] Dickson DW, Braak H, Duda JE, et al. Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria [J]. Lancet Neurol,2009, 8(12):1150-1157.
[25] Amoroso N, Rocca ML, Monaco A, et al. Complex networks reveal early MRI markers of Parkinson’s disease [J]. Med Image Anal, 2018, 48:12-24.
[26] Schwarz ST, Afzal M, Morgan PS, et al. The‘swallow tail’ appearance of the healthy nigrosome-a new accurate test of Parkinson’s disease: a case-control and retrospective cross-sectional MRI study at 3T [J]. PLoS One, 2016, 9(4):e93814.
|